Literature DB >> 12068086

Specificity of resistance to oxidative stress.

Richard Dargusch1, David Schubert.   

Abstract

Two clonal nerve-like cell lines derived from HT22 and PC12 have been selected for resistance to glutamate toxicity and amyloid toxicity, respectively. In the following experiments it was asked if these cell lines show cross-resistance toward amyloid beta peptide (Abeta) and glutamate as well as toward a variety of additional neurotoxins. Conversely, it was determined if inhibitors of oxytosis, a well-defined oxidative stress pathway, also protect cells from the neurotoxins. It is shown that both glutamate and amyloid resistant cells are cross resistant to most of the other toxins or toxic conditions, while inhibitors of oxytosis protect from glutathione and cystine depletion and H2O2 toxicity, but not from the toxic effects of nitric oxide, rotenone, arsenite or cisplatin. It is concluded that while there is a great deal of cross-resistance to neurotoxins, the components of the cell death pathway which has been defined for oxytosis are not used by many of the neurotoxins.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12068086     DOI: 10.1046/j.1471-4159.2002.00950.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  18 in total

Review 1.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.

Authors:  Jan Lewerenz; Sandra J Hewett; Ying Huang; Maria Lambros; Peter W Gout; Peter W Kalivas; Ann Massie; Ilse Smolders; Axel Methner; Mathias Pergande; Sylvia B Smith; Vadivel Ganapathy; Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2012-08-03       Impact factor: 8.401

2.  Mutation of ATF4 mediates resistance of neuronal cell lines against oxidative stress by inducing xCT expression.

Authors:  J Lewerenz; H Sato; P Albrecht; N Henke; R Noack; A Methner; P Maher
Journal:  Cell Death Differ       Date:  2011-11-18       Impact factor: 15.828

3.  Proteasome inhibition protects HT22 neuronal cells from oxidative glutamate toxicity.

Authors:  Klaus van Leyen; Ambreena Siddiq; Rajiv R Ratan; Eng H Lo
Journal:  J Neurochem       Date:  2005-02       Impact factor: 5.372

4.  Nanomolar vitamin E alpha-tocotrienol inhibits glutamate-induced activation of phospholipase A2 and causes neuroprotection.

Authors:  Savita Khanna; Narasimham L Parinandi; Sainath R Kotha; Sashwati Roy; Cameron Rink; Douglas Bibus; Chandan K Sen
Journal:  J Neurochem       Date:  2009-12-17       Impact factor: 5.372

Review 5.  Killer proteases and little strokes--how the things that do not kill you make you stronger.

Authors:  Anne E O'Duffy; Yvette M Bordelon; BethAnn McLaughlin
Journal:  J Cereb Blood Flow Metab       Date:  2006-08-09       Impact factor: 6.200

Review 6.  Back to the future with phenotypic screening.

Authors:  Marguerite Prior; Chandramouli Chiruta; Antonio Currais; Josh Goldberg; Justin Ramsey; Richard Dargusch; Pamela A Maher; David Schubert
Journal:  ACS Chem Neurosci       Date:  2014-06-05       Impact factor: 4.418

7.  Characterization of the neuroprotective potential of derivatives of the iron chelating drug deferiprone.

Authors:  Pamela Maher; George J Kontoghiorghes
Journal:  Neurochem Res       Date:  2015-01-06       Impact factor: 3.996

8.  Characterization of the potent neuroprotective properties of the natural vitamin E alpha-tocotrienol.

Authors:  Savita Khanna; Sashwati Roy; Narasimham L Parinandi; Mariah Maurer; Chandan K Sen
Journal:  J Neurochem       Date:  2006-09       Impact factor: 5.372

9.  Carnosic acid, a catechol-type electrophilic compound, protects neurons both in vitro and in vivo through activation of the Keap1/Nrf2 pathway via S-alkylation of targeted cysteines on Keap1.

Authors:  Takumi Satoh; Kunio Kosaka; Ken Itoh; Akira Kobayashi; Masayuki Yamamoto; Yosuke Shimojo; Chieko Kitajima; Jiankun Cui; Joshua Kamins; Shu-ichi Okamoto; Masanori Izumi; Takuji Shirasawa; Stuart A Lipton
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

10.  Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration.

Authors:  Savita Khanna; Sashwati Roy; Hoon Ryu; Praveen Bahadduri; Peter W Swaan; Rajiv R Ratan; Chandan K Sen
Journal:  J Biol Chem       Date:  2003-08-13       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.